Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
lunedì, novembre 02
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
NRC Health
NRC
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$23.83
0.34
1.45%
Ult. Agg.: Oct 30, 4:00 PM
Get Report
Panoramica
Notizie
Previsioni utili
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Dividendi
Confronta
Opzioni
Rapporto azionario
Utili:
I risultati di Q3 2026 sono stati pubblicati in data mar ott 27th, dopo la chiusura del mercato
Conference call:
La conference call più recente è iniziata alle 4:30 PM, 6 giorni fa
Clicca per vedere il webcast
NRC Health Financials
NRC Health (NRC) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
National Research Q3 Adj. EPS $0.21, Inline, Sales $38.399M Beat $35.800M Estimate
National Research (NASDAQ:NRC) reported quarterly earnings of $0.21 per share which met the analyst consensus estimate. This is a 8.7 percent decrease over earnings of $0.23 per share from the same period last year.
Benzinga Newsdesk
PRO
National Research Q2 Adj. EPS $0.31 Beats $0.14 Estimate, Sales $35.392M Beat $34.900M Estimate
National Research (NASDAQ:NRC) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of $0.14 by 121.43 percent. This is a 10.71 percent increase over earnings of $0.28 per share from
Benzinga Newsdesk
PRO
National Research Q1 Adj. EPS $0.21 Down From $0.25 YoY, Sales $34.803M Up From $33.551M YoY
Benzinga Newsdesk
PRO
National Research Q4 Adj. EPS $0.16 Down From $0.28 YoY, Sales $35.193M Down From $36.907M YoY
Benzinga Newsdesk
Earnings Scheduled For February 3, 2026
Benzinga Insights
PRO
National Research Q3 Adj. EPS $0.23 Down From $0.25 YoY, Sales $34.819M Down From $35.819M YoY
National Research (NASDAQ:NRC) reported quarterly earnings of $0.23 per share. This is a 8 percent decrease over earnings of $0.25 per share from the same period last year. The company reported $34.819 million in sales
Benzinga Newsdesk
